Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 9/20 | 0.60 |
| ▸ | CDK4 | P11802 | 8/20 | 0.60 |
| ▸ | EIF2AK2 | P19525 | 5/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.45 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.45 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8317316 | 0.90 | CDK2 (0.74) | CDK2CDK4EIF2AK2KDM4EALDH1A1 | |
| SCHEMBL8316804 | 0.90 | CDK4 (0.59) | CDK2CDK4EIF2AK2KMT2AALDH1A1 | |
| SCHEMBL8324791 | 0.89 | EIF2AK2 (0.61) | CDK2CDK4EIF2AK2KDM4EALDH1A1 | |
| SCHEMBL14011222 | 0.87 | CDK2 (0.59) | CDK2CDK4 | |
| SCHEMBL8325791 | 0.87 | CDK2 (0.56) | CDK2CDK4MEN1KMT2AKDM4E | |
| SCHEMBL8324564 | 0.83 | CDK4 (0.66) | CDK2CDK4EIF2AK2KDM4E | |
| SCHEMBL4424686 | 0.81 | CDK4 (0.48) | CDK2CDK4EIF2AK2KDM4EALDH1A1 | |
| SCHEMBL14011223 | 0.80 | CDK4 (0.50) | CDK2CDK4EIF2AK2 | |
| SCHEMBL8326117 | 0.80 | CDK2 (0.51) | CDK2CDK4EIF2AK2PIK3CAPIK3CB | |
| SCHEMBL4425029 | 0.79 | EIF2AK2 (0.46) | CDK2CDK4EIF2AK2ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7456190-B2 | Compositions useful as protein kinase inhibitors | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2008-11-25 | — | — | US | disclosed |
| US-7456190-B2 | Compositions useful as protein kinase inhibitors | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2008-11-25 | — | — | US | disclosed |
| WO-2004083203-A1 | COMPOSITIONS USEFUL AS PROTEIN KINASE INHIBITORS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2004-09-30 | — | — | WO | disclosed |